LiverMRDoc Pro helped doctors find more liver lesions on MRI

In the maker's trial that China's CMDE reviewed, doctors using LiverMRDoc Pro had lesion-level sensitivity for focal liver lesions 0.0969 higher than without it.

  • Not rated an organization

    Doctors read stored images in the maker's pre-market trial, and no patient's care depended on the software.

Depth runs from 1, a convenience or time saved, to 5, a life or a livelihood preserved.

Status
Intended benefit.
Evidence

foundstudiedreportedclaimed

An independent regulatory document supports the benefit.

Compared with

The same doctors reading the same liver MRI cases without the software, with an expert consensus as the reference. Measured.

The system’s part
In a fully crossed design, doctors read every case with and without the software, so the gain in sensitivity is attributed to the software. The trial was the maker's own. The report says that segmentation and lesion analysis use deep learning.
Not yet checked
LimitsCosts and harmsLearns from dataLater outcome

Download data Cite Suggest a correction

Benefit type
Improved Task Accuracy
System
LiverMRDoc Pro (肝脏局灶性病变MR图像辅助评估软件)
Made by
Yukun (Beijing) Network Technology Co., Ltd. (语坤（北京）网络科技有限公司)
Used by
Yukun (Beijing) Network Technology (retrospective reader trial on 392 cases at five hospitals)
Where
Beijing Friendship Hospital of Capital Medical University, Ningbo Hwa Mei Hospital of the University of Chinese Academy of Sciences, Affiliated Hospital of Hebei University, First Affiliated Hospital of Xi'an Jiaotong University and Huazhong University of Science and Technology Union Shenzhen Hospital, China
Stage
Tested in a laboratory
Date
, when the source was published
Kind
Aggregate result
Broad benefit
Identifying Objects, Actions, and Events
Collections
Scrutiny and findings
Last revised
1 November 2026

Sources

  1. Regulatory document, by authors with no tie to the system.

    Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告：肝脏局灶性病变MR图像辅助评估软件 (technical review report for the registration of focal liver lesion assessment-aid software for MR images), acceptance no. CQZ2301004, applicant 语坤（北京）网络科技有限公司. 18 July 2024. Section 三、临床评价概述 (clinical evaluation).

    FAS 集：灵敏度差值为 0.0969，95%置信区间为(0.0840，0.1099)，区间下限大于目标值 0，优效性假设成立。
    在目前认知水平上，该产品上市带来的受益大于风险，符合现行的技术审评要求，建议予以注册。

Details

AI system

Reported configuration

Release 2 (full version 2.0.0.001)

Workflow

The software segmented the liver, its segments, vessels and lesions with deep learning and named the liver segments. It flagged suspected focal lesions of 5 mm or more for the reading doctor.

Follow-up

Conditions for replication

Patients are adults having liver MRI. Trained doctors read the images and do not base a clinical decision on the software alone.

Entry details

Sector

Healthcare.

Purpose

Yukun (Beijing) Network Technology built LiverMRDoc Pro to help trained doctors detect focal liver lesions of 5 mm or more on adult liver MRI.

29 more questions not yet checked

model, provider, role, configuration, inputs and outputs, autonomy, human oversight, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.

Cite this record

Peter H. Vartanian. (2026). LiverMRDoc Pro helped doctors find more liver lesions on MRI (AIBD-1062). Artificial Intelligence Benefits Database, edition of 1 November 2026. https://petervartanian.xyz/aibd/records/AIBD-1062.html (archived at https://doi.org/10.7910/DVN/AADSII, version 7.0)

BibTeX Data Field definitions